Cargando…

Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer

Background: The effect of adjuvant chemotherapy on stage II colon cancer remains constantly controversial. Recently, however, several studies have reported the definite survival benefit of adjuvant chemotherapy (ACT) in T4 disease (stage IIB and IIC) among stage II colon cancer patients. The followi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qi, Luo, Dakui, An, Hongyin, Zhang, Sheng, Cai, Sanjun, Li, Qingguo, Li, Xinxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400679/ https://www.ncbi.nlm.nih.gov/pubmed/30854130 http://dx.doi.org/10.7150/jca.28917

Ejemplares similares

Evaluating the Guiding Role of Elevated Pretreatment Serum Carcinoembryonic Antigen Levels for Adjuvant Chemotherapy in Stage IIA Colon Cancer: A Large Population-Based and Propensity Score-Matched Study
por: Liu, Qi, et al.
Publicado: (2019)

P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management
por: Liu, Qi, et al.
Publicado: (2018)

Real-World Implications of Nonbiological Factors with Staging, Prognosis and Clinical Management in Colon Cancer
por: Liu, Qi, et al.
Publicado: (2018)

Associations of P Score With Real-World Survival Improvement Offered by Adjuvant Chemotherapy in Stage II Colon Cancer: A Large Population-Based Longitudinal Cohort Study
por: Liu, Qi, et al.
Publicado: (2021)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
por: Lee, Mok-Won, et al.
Publicado: (2021)

Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
por: Liu, Qi, et al.
Publicado: (2019)

Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer
por: Liu, Qi, et al.
Publicado: (2020)

A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer
por: Luo, Dakui, et al.
Publicado: (2020)

Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study
por: Luo, Dakui, et al.
Publicado: (2019)

Evaluation of Traditional Prognostic Factors for Stage I-III Colorectal Cancer Patients Who Survived for Over Five Years After Surgery
por: Luo, Dakui, et al.
Publicado: (2021)

Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum
por: Li, Qingguo, et al.
Publicado: (2017)

Combination of carcinoembryonic antigen with the American Joint Committee on Cancer TNM staging system in rectal cancer: a real-world and large population-based study
por: Liu, Qi, et al.
Publicado: (2018)

Incidence, predictors and prognostic implications of positive circumferential resection margin in colon cancer: A retrospective study in a Chinese high-volume cancer center
por: Luo, Dakui, et al.
Publicado: (2022)

Evaluating the Effect of Lymph Node Status on Survival in Large Colon Cancer
por: Liu, Qi, et al.
Publicado: (2018)

Circumferential resection margin as a prognostic factor after rectal cancer surgery: A large population‐based retrospective study
por: Liu, Qi, et al.
Publicado: (2018)

Pretreatment Carcinoembryonic Antigen Level Serves as a Potential Biomarker to Guide Adjuvant Radiotherapy in pT4N+ Colon Cancer Patients
por: Luo, Dakui, et al.
Publicado: (2023)

Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer
por: Chen, Po-Huang, et al.
Publicado: (2022)

Clinicopathological Features of Stage I–III Colorectal Cancer Recurrence Over 5 Years After Radical Surgery Without Receiving Neoadjuvant Therapy: Evidence From a Large Sample Study
por: Luo, Dakui, et al.
Publicado: (2021)

ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial
por: Li, Qingguo, et al.
Publicado: (2019)

LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer
por: Zhuo, Changhua, et al.
Publicado: (2015)

The influence of marital status on stage at diagnosis and survival of patients with colorectal cancer
por: Li, Qingguo, et al.
Publicado: (2015)

The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy
por: Luo, Dakui, et al.
Publicado: (2021)

Proteomic profiling reveals a signature for optimizing prognostic prediction in Colon Cancer
por: Shan, Zezhi, et al.
Publicado: (2021)

Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis
por: Li, Qingguo, et al.
Publicado: (2018)

Effect of interval between neoadjuvant chemoradiotherapy and surgery on oncological outcomes in poor responders with locally advanced rectal cancer: a retrospective cohort study
por: Luo, Dakui, et al.
Publicado: (2023)

Indication for and Effect of Adjuvant Chemotherapy for Stage IIa (T3N0M0) Colon Cancer
por: Jeon, Chul-Hyo, et al.
Publicado: (2019)

Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer
por: Lee, Kil-yong, et al.
Publicado: (2019)

Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non‐small cell lung cancer
por: Zhang, Pei, et al.
Publicado: (2020)

Extramural extension as indicator for postoperative adjuvant chemotherapy in Stage IIA (pT3N0) colon cancer
por: Akagi, Yoshito, et al.
Publicado: (2013)

Survival Contradiction Between Stage IIA and Stage IIIA Rectal Cancer: A Retrospective Study
por: Mo, Shaobo, et al.
Publicado: (2018)

Effect of Lymph Node Count on Pathological Stage III Rectal Cancer with Preoperative Radiotherapy
por: Li, Qingguo, et al.
Publicado: (2015)

Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB–IIA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2022)

Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy
por: Liang, Lei, et al.
Publicado: (2015)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

Immunological nomograms predicting prognosis and guiding adjuvant chemotherapy in stage II colorectal cancer
por: Feng, Yang, et al.
Publicado: (2019)

Radiotherapy for stage IIA rectal cancer may not benefit all
por: Hu, Xiang, et al.
Publicado: (2017)

Pathological Features and Survival Outcomes of Young Patients with Operable Colon Cancer: Are They Homogeneous?
por: Li, Qingguo, et al.
Publicado: (2014)

Changes in Incidence and Survival by Decade of Patients With Primary Colorectal Lymphoma: A SEER Analysis
por: Li, Qingguo, et al.
Publicado: (2020)

Negative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancer
por: Li, Qingguo, et al.
Publicado: (2016)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j7d471hcrohca21squlhvsbhr0